Eye drug safety check: 480 patients monitored in real practice
NCT ID NCT04519619
Summary
This study is observing how well the eye injection medication Eylea works and what side effects occur when used in regular medical practice for neovascular glaucoma. Doctors will follow 480 patients in Japan for 6 months after they start treatment. The goal is to understand the real-world safety and effectiveness of this already-approved medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Many locations
RECRUITINGMultiple Locations, Japan
Conditions
Explore the condition pages connected to this study.